Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides

StatusActive, Not Recruiting
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 5 more changesShow less
    • Enrollment target: estimated 50 to confirmed 49
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 4 of 6 entries
    • Study description revised
    • Site details revised
  2. 2 versions Re-verified since Oct 31, 2025, no change to tracked fieldsv15-v16
  3. Primary and study completion dates: Dec 31, 2024 to Dec 31, 2027v14
  4. 5 versions Re-verified since Dec 12, 2022, no change to tracked fieldsv9-v13
  5. Primary completion date: Sep 30, 2020 to Dec 31, 2024
    • Study completion date: Sep 30, 2021 to Dec 31, 2024
    v8
Show 6 earlier versionsHide 6 earlier versions
  1. Re-verified, no change to tracked fieldsv7
  2. Primary endpoint revisedv6 Show 9 more changesShow less
    • Primary completion date: Sep 2020 to Sep 30, 2020
    • Study completion date: Sep 2021 to Sep 30, 2021
    • Interventions: Microbiome Analysis (Procedure), Photographs (Other), Radiation Therapy (Radiation), Symptom Questionnaire (Behavioral) to Quality-of-Life Assessment (Other), Questionnaire Administration (Other), Radiation Therapy (Radiation)
    • Secondary endpoints: 3 to 6
    • Study description shortened, about 210 words
    • Study site revised
    • Study title revised
    • Eligibility criteria shortened, about 2 words
    • Collaborators expanded, about 4 words
  3. Study description expanded, about 50 words
    • Site contact updated
    v5
  4. Re-verified, no change to tracked fieldsv4
  5. Enrollment target: 20 to 50
    • Study completion date: Sep 2020 to Sep 2021
    • Eligibility criteria expanded, about 70 words
    • Study description expanded, about 26 words
    v3
  6. Study description revisedv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This phase II trial studies how well ultra low dose radiation therapy works in treating patients with mycosis fungoides. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving ultra low doses of radiation may help control the disease and reduce side effects compared to treatment with higher doses.
Trial Details
NCT Number NCT03398161
Lead Sponsor M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Localized Skin Lesion, Mycosis Fungoides
Related terms Mycosis Fungoides
Enrollment 49 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov